by TractManager | May 22, 2020 | Health Technology Assessment
Focus of the Report: Use of botulinum toxin (BTX) for treatment of gastroparesis.Technology Description: BTX, a neurotoxin produced by the bacterium Clostridium botulinum, inhibits the release of the neurotransmitter acetylcholine at the neuromuscular junction and...
by TractManager | May 21, 2020 | Molecular Test Assessment
This report evaluates the analytical validity, clinical validity, and clinical utility of the FilmArray Respiratory Panel.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | May 18, 2020 | Health Technology Assessment
Focus of the Report: This report evaluates the use of autologous concentrated bone marrow aspirate (CBMA) for spinal fusion surgeries.Technology Description: Autologous CBMA may be implanted during spinal fusion procedures alone or as an adjunct to other bone grafting...
by TractManager | May 13, 2020 | COVID-Articles, Emerging Technology Report
Chloroquine (and its metabolite, hydroxychloroquine) is an oral 4-aminoquinoline antimalarial agent that has demonstrated antiviral effects on SARS-CoV and SARS-CoV-2 in vitro. It is being evaluated for the treatment of COVID-19.If you have a Hayes login, click here...
by TractManager | May 12, 2020 | Health Technology Assessment
Focus of the Report: The use of the gammaCore (electroCore Medical LLC) noninvasive vagus nerve stimulator for the acute treatment or prevention of episodic and chronic cluster headaches (eCH and cCH).Technology Description: The gammaCore stimulator is a small,...
Recent Comments